StonvexLoading…
StonvexStonvexStonvexCore line items from ABCB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.39B | $1.38B | $1.28B | $893.89M |
Operating Income | $533.76M | $475.86M | $356.94M | $453.10M |
Net Income | $412.15M | $358.69M | $269.11M | $346.54M |
EPS (Diluted) | $6.00 | $5.19 | $3.89 | $4.99 |
Total Assets | $27.52B | $26.26B | $25.20B | $25.05B |
Total Liabilities | $23.44B | $22.51B | $21.78B | $21.86B |
Cash & Equivalents | $1.09B | $1.22B | $1.17B | $1.12B |
Free Cash Flow OCF − CapEx | $369.64M | $140.72M | $551.43M | $1.05B |
Shares Outstanding | 68.71M | 69.06M | 69.10M | 69.42M |